XML 59 R45.htm IDEA: XBRL DOCUMENT v3.21.1

2. Summary of Significant Accounting Policies (Details Narrative) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Patent acquisition expenses	$ 0	$ 0
Measurement Input, Price Volatility [Member] | Embedded Derivative [Member]
Assumptions used for derivatives	29%	30%
Measurement Input, Price Volatility [Member] | Black Scholes Model [Member] | Series A Warrants [Member]
Assumptions used for derivatives	29%	30%
Measurement Input, Price Volatility [Member] | Monte Carlo Method [Member] | Restricted Stock Units [Member]
Assumptions used for derivatives	38%
Measurement Input, Price Volatility [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Scenario 1 [Member]
Assumptions used for derivatives	29%
Measurement Input, Price Volatility [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Scenario 2 [Member]
Assumptions used for derivatives	50%
Measurement Input, Risk Free Interest Rate [Member] | Embedded Derivative [Member]
Assumptions used for derivatives	.62%	1.86%
Measurement Input, Risk Free Interest Rate [Member] | Black Scholes Model [Member] | Series A Warrants [Member]
Assumptions used for derivatives	.62%	1.85%
Measurement Input, Risk Free Interest Rate [Member] | Monte Carlo Method [Member] | Restricted Stock Units [Member]
Assumptions used for derivatives	1.38%
Measurement Input, Risk Free Interest Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Scenario 1 [Member]
Assumptions used for derivatives	.63%
Measurement Input, Risk Free Interest Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Scenario 2 [Member]
Assumptions used for derivatives	.12%
Measurement Input, Expected Term [Member] | Black Scholes Model [Member] | Series A Warrants [Member]
Assumptions used for derivatives	6.79 years	7.79 years
Measurement Input, Expected Term [Member] | Monte Carlo Method [Member] | Restricted Stock Units [Member]
Assumptions used for derivatives	3.00 years
Measurement Input, Expected Term [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Scenario 1 [Member]
Assumptions used for derivatives	6.87 years
Measurement Input, Expected Term [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Scenario 2 [Member]
Assumptions used for derivatives	1.65 years
Measurement Input, Expected Dividend Rate [Member] | Embedded Derivative [Member]
Assumptions used for derivatives	0%	0.00%
Measurement Input, Expected Dividend Rate [Member] | Black Scholes Model [Member] | Series A Warrants [Member]
Assumptions used for derivatives	0%	0.00%
Measurement Input, Expected Dividend Rate [Member] | Monte Carlo Method [Member] | Restricted Stock Units [Member]
Assumptions used for derivatives	0%
Measurement Input, Expected Dividend Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Scenario 1 [Member]
Assumptions used for derivatives	0%
Measurement Input, Expected Dividend Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Scenario 2 [Member]
Assumptions used for derivatives	0%
Measurement Input, Discount Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Scenario 1 [Member]
Assumptions used for derivatives	10%
Measurement Input, Discount Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Scenario 2 [Member]
Assumptions used for derivatives	10%
Measurement Input, Credit Spread [Member] | Embedded Derivative [Member]
Assumptions used for derivatives	19%	25%
Revenue Benchmark [Member] | One Licensee [Member]
Concentration risk percentage	64.00%	43.00%
Revenue Benchmark [Member] | One Licensee 2 [Member]
Concentration risk percentage	10.00%	22.00%
Revenue Benchmark [Member] | One Licensee 3 [Member]
Concentration risk percentage	7.00%	15.00%
Accounts Receivable [Member] | One Licensee [Member]
Concentration risk percentage	62.00%	70.00%
Accounts Receivable [Member] | One Licensee 2 [Member]
Concentration risk percentage	21.00%	17.00%
Accounts Receivable [Member] | One Licensee 4 [Member]
Concentration risk percentage	3.00%

X

- Definition

Patent acquisition expenses

+ References

No definition available.

+ Details

Name:	ACTG_PatentAcquisitionExpenses
Namespace Prefix:	ACTG_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Describes how an entity determines the fair values of its derivatives, including its valuation methodology and significant assumptions used.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959

+ Details

Name:	us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_DerivativeInstrumentRiskAxis=ACTG_EmbeddedDerivativeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ValuationTechniqueAxis=ACTG_BlackScholesModelMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_DerivativeInstrumentRiskAxis=ACTG_SeriesAWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ValuationTechniqueAxis=ACTG_MonteCarloMethodMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardTypeAxis=ACTG_RestrictedStockUnitsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_DerivativeInstrumentRiskAxis=ACTG_SeriesBWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_NonmonetaryTransactionTypeAxis=ACTG_Scenario1Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_NonmonetaryTransactionTypeAxis=ACTG_Scenario2Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TransactionTypeAxis=ACTG_Scenario1Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicenseeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee2Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee3Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee4Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: